HIV/STD Testing and Diagnosis

The sexually transmitted diseases Testing Market is forecast to reach $167.4 billion by 2020, registering a CAGR of 8.5% during 2014-2020. STDs are a grave issue globally, and are responsible for high morbidity in adults and cause infertility in both men and women. Diagnostic procedures of STDs market include the technologies that are used to identify and analyze STD along with the laboratories where the tests are carried out. Diagnostic testing programs are implemented by health care departments in developed regions for prevention and control of transmission, specifically of P&S Syphilis, Chlamydia, Gonorrhea and HPV. HPV testing volume and revenue will grow at much faster rate owing to higher incidences in Asia Pacific region.

 

  • Track 1-1 Blood/Serum testing
  • Track 2-2 PCR testing
  • Track 3-3 POC testing
  • Track 4-4 Immunochromatographic assays
  • Track 5-5 Flow Cytometers
  • Track 6-6 Differential Light Scattering machines
  • Track 7-7 Phone chips
  • Track 8-8 Rapid diagnostic kits
  • Track 9-9 Absorbance microplate reader
  • Track 10-10 CICT/PICT testing
  • Track 11-11 CSF examination
  • Track 12-12 Whiff test

Related Conference of Infectious Diseases